| NCT Number | NCT07684937 |
| Lead Sponsor | Hangzhou Highlightll Pharmaceutical Co., Ltd |
| Conditions | Atopic Dermatitis |
| Enrollment | 36 participants |
| Start Date | 2024-06-14 |
| Primary Completion | 2024-11-25 (estimated) |
| Study Completion | 2024-11-25 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-06 |